|
Scientific Programme
|
|
|
|
Track Information |
|
|
|
Fundacao Oswaldo Cruz, Brazil
University of Liverpool, UK
Indian Institute of Toxicology Research, India
Institute of Chemical Technology, India
University
of California, USA
|
Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 ms,
MRC Centre for Drug Safety Science,
Dept. Pharmacology |
Track
5-1: Biomarkers in Toxicology |
Session Chair: |
Dr. Rita Mattos,
Senior Researcher,
National School of Public Health,
Fundacao Oswaldo Cruz,
Ministry of Health, Brazil.
|
Session Co-Chair:
|
Dr. Dominic Willia,
MRC Centre for Drug Safety Science,
Dept. Pharmacology & Therapeutics,
Sherrington Building,
The University of Liverpool,
Liverpool, UK.
|
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Dr. Kar Chowdhuri,
Scientist F and Deputy Director,
Embryotoxicology Lab,
Indian Institute of Toxicology Research,
P.O. Box No. 80,
Mahatma Gandhi Marg,
Lucknow 226 001,
Uttar Pradesh,
India.
|
8:35-9:00 |
Title: Advances and
Strategies in Using Biomarkers in Children Lead Exposure
Dr. Rita Mattos,
Senior Researcher,
National School of Public Health,
Fundacao Oswaldo Cruz,
Ministry of Health, Brazil.
|
9:25-9:50 |
Dr. Maibach Howard, Dermatology,
University of
California, Sanfransisco, CA, USA.
|
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title: Biomarkers of
Drug-Induced Liver Injury
Dr. Dominic Williams,
MRC Centre for Drug Safety Science,
Dept. Pharmacology & Therapeutics,
Sherrington Building,
The University of Liverpool,
Liverpool, UK.
|
11:15-11:40
|
Title: Biomarkers in
Neurotoxicity
Dr. Sadhana Sathaye,
Reader in Pharmacy,
Dept. of Pharm. Sci. and Tech.,
Institute of Chemical Technology,
Matunga, Mumbai, India.
|
11:40-12:00 |
Panel Discussion |
|
|
Bio-Acoustic-MEMS in Medicine Laboratory, USA
Synthon BV,
The Netherlands
Research Center for Pharmaceutical Nanotechnology, Iran
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track
5-2: Toxicogenomics & Metabolomics |
Session
Chair: |
Call for Host |
Session Co-Chair:
|
Dr. Utkan Demirci,
Bio-Acoustic-MEMS in Medicine (BAMM)Laboratory,
Center for Bioengineering,
Department of Medicine,
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
|
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Dr. Utkan Demirci,
Bio-Acoustic-MEMS in Medicine (BAMM)Laboratory,
Center for Bioengineering,
Department of Medicine,
Brigham and Women’s Hospital,
Harvard Medical School,
Boston, MA, USA.
|
13:55-14:20 |
Dr. Sandra van Os,
Project Leader Clinical R&D,
Synthon BV,
Microweg 22,
6503 GN Nijmegen,
The Netherlands.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Nonviral
Cationic Gene Delivery Nanosystems: Geno compatibility and
Toxicogenomics Dilemma
Dr. Y. Omidi,
Associate Professor, Faculty of Pharmacy,
Director, Research Center for Pharmaceutical
Nanotechnology,
Dean, School of Advanced Biomedical Sciences,
Tabriz University of Medical Sciences,
Tabriz, Iran.
|
17:35-18:00 |
Panel Discussion |
|
|
Al-Qassim University,
Saudi Arabia
University
of Madras, India
SRM
University, India
University
of Peradeniya,
Sri Lanka
National Institute for
Research in Reproductive Health, India
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track
5-3: Environmental Toxicology |
Session
Chair: |
Call for Host |
Session Co-Chair:
|
Dr. Sivakumar
Gowder, Associate Professor,
Dept. Pharmacology & Biochemistry, Al-Qassim
University,
College of Pharmacy, Buraidah, Saudi
Arabia. |
8:30-8:35 |
Session Introduction |
9:00-9:25
|
Title: Effect of
Antioxidants on PCB Induced Changes in Male Reproduction
Dr. Arunakaran J, Department of
Endocrinology,
Dr. ALM PGIBMS,
University of Madras,
Chennai,
India.
|
9:25-9:50 |
Title: Composite
Ion Exchange Materials and their Applications to Remove Toxic Metal
Ions
Dr. MU. Naushad, SRM University,
NCR Campus,
Modinagar, India.
|
9:50-10:15
|
Title: Kidney, the
Major Organ in the Body to Evaluate Toxic and Transport Properties of
Environmental Chemicals
Dr. Sivakumar Gowder, Associate
Professor,
Dept. Pharmacology & Biochemistry, Al-Qassim
University,
College of Pharmacy, Buraidah, Saudi
Arabia.
|
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title: Impact of
Melatonin on PCB Induced Neurotoxicity
Dr. P. Venkataraman.
Assistant Professor,
Department of Medical Research,
SRM Medical College Hospital and Research
Centre,
SRM University, Kattankulathur - 603 203.
India.
|
10:50-11:15 |
Title:
Attitude and Knowledge of Nonsmokers about Secondhand Smoke and their
Opinion towards Cessation of Smoking in Malaysia – Findings from
International Tobacco Control (ITC) Survey Malaysia
Dr. Mohamed Shukry Zawahir,
South Asian Clinical Toxicology Research
Collaboration,
Faculty of Medicine, University of Peradeniya,
Peradeniya,
Sri Lanka.
|
11:15-11:40 |
Title: Exposure to
Bisphenol A, an Environmental Estrogen on Reproductive Health
Dr. Geeta Vanage,
National Center for Preclinical Reproductive and
Genetic Toxicology,
National Institute for Research in Reproductive
Health (ICMR),
Street, Parel, Mumbai 400 012, Maharashtra, India.
|
11:40-12:00 |
Panel Discussion |
|
|
Indian
Institute of Chemical Technology, India
Centre
for Cellular and Molecular Biology, India
Yokohama City University, Japan
Children's Hospital Medical Center, USA
Philip Morris International
Radboud
University Nijmegen Medical Center, The Netherlands
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track
5-4: Molecular Epidemiology |
Session
Chair:
|
Dr. U. S. N Murthy,
Director Grade Scientist/Scientist G,
Head Biology Division,
Indian Institute of Chemical Technology (CSIR),
Ministry of Science and Technology Govt India,
Tarnaka, Hyderabad, India. |
Session Co-Chair:
|
Dr. M.V
Jagannadham,
Scientist, Centre for Cellular and Molecular
Biology,
Tarnaka, Hyderabad -500 007, India. |
13:00-13:05 |
Session Introduction |
13:30-13:55 |
Dr. Yoshihiro Ishikawa,
Dean, Graduate School of Medicine,
Professor and President,
Cardiovascular Research Institute,
Yokohama City University,
Graduate School of Medicine,
Jap
|
13:55-14:20 |
Prof. Michael V. Miles,
Clinical Pediatrics and Neurology,
Div. of Pathology & Laboratory Medicine,
Children's Hospital Medical Center,
3333 Burnet Ave.,
Cincinnati,
OH 45229, USA.
|
14:20-14:45
|
Title: Cigarette Smoke
Inhalation Study for Lung Tumorigenicity in A/J Mice
Dr. Rosemarie B. Lichtner,
Philip Morris Research Laboratories GmbH, Germany.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Prof. Thamar Stollman, Department
of Surgery,
Radboud University Nijmegen Medical Center,
Nijmegen,
The Netherlands.
|
16:45-17:10
|
Title:
Artificial Intelligence : A Magic
Bullet for Epidemiological Studies of Vector Borne Diseases
Dr. U.S.N Murthy,
Director Grade Scientist/Scientist G,
Head Biology Division,
Indian Institute of Chemical Technology (CSIR),
Ministry of Science and Technology Govt India,
Tarnaka, Hyderabad, India.
|
17:10-17:35
|
Title: The Proteome of
the Outer Membrane Vesicles of an Antarctic Bacterium Pseudomonas
Syringae
Dr. M.V Jagannadham,
Scientist, Centre for Cellular and Molecular
Biology,
Tarnaka, Hyderabad, India.
|
17:35-18:00 |
Panel Discussion |
|
|
|
Track
6: PK/PD and Drug Discovery |
|
Shandong University School Of Medicine, China
Aizant
Drug Research Solutions, India
Piramal
Life Sciences, India
Meerut
Institute of Engineering and Technology, India
Florida
A & M University, USA
Indian
Institute of Technology, India
|
Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 |
Track
6-1: Anticancer, Antiviral Drug Development |
Session
Chair: |
Dr. Harish Joshi,
Laboratory of Drug Discovery,
Design and Research,
Department of Cell Biology,
Suite 455 Whitehead Bld., WBRB,
615 Michael Street,
Atlanta,
GA-30322, USA.
|
Session
Co-Chair: |
Dr. Guo Rui Chen,
Institute of Clinical Pharmacology,
Qilu Hospital of Shandong University, Jinan,
Shandong, China. |
8:30-8:35 |
Session Introduction |
8:35-9:00
|
Title:
Challenges in siRNA/shRNA Delivery
and Development of RNAi Therapeutics for Cancer
Dr. Tathagata Dutta,
Deputy Director,
Formulation Developm Tathagata Duttaent
and Drug Discovery Research,
Aizant Drug Research Solutions,
Hyderabad, India.
|
9:00-9:25 |
Title:
Pharmacokinetics,
Metabolism and Tissue Distribution of
Norcantharidin in Human Body,
Studied by HPLC-MS/MS and Isotope-labeled
Methods
Dr. Guo Rui Chen, Institute
of Clinical Pharmacology,
Qilu Hospital of Shandong University, Jinan,
Shandong, China.
|
9:25-9:50 |
Title: Recent Advances
in Anticancer Drug Discovery: Multiple Target Approach to Tackle Tough
Tumors
Dr. Sanjay Kumar, Group Leader,
Department of Medicinal Chemistry,
Piramal Life Sciences,
Nirlon Complex, Off Western Express Highway,
Goregaon (E),
Mumbai 400 063, India.
|
9:50-10:15 |
Title:
Quantitative Structure-Activity
Relationship Studies on Anti-Hepatitis Viral Agents
Dr. S.P.Gupta, Departemt
of Pharmaceutical Technology,
Meerut Institute of Engineering and Technology,
Meerut, India.
|
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Title:
Targetted therapy for Treatment of
Lung Cancer
Dr. Mandip Singh Sachdeva,
Professor and section Leader, Pharmaceutics,
Florida A & M University,
College of Pharmacy,
Editor in Chief, CRC Critical Reviews in
Therapeutic Drug Carrier Systems,
Tallahassee, Florida, USA.
|
10:50-11:15 |
Title: Hopeful Trip
from Herbs to Humans
Dr. Harish Joshi,
Laboratory of Drug Discovery,
Design and Research,
Department of Cell Biology,
Suite 455 Whitehead Bld., WBRB,
615 Michael Street,
Atlanta,
GA-30322, USA.
|
11:15-11:40 |
Title:
Nano-drug Deliverysystem
Particularly for Anti-cancer Drug
Prof P.Pramanik,
nano-materials laboratory,
Chemistry Department,
Indian Institute of Technology,
Kharagpur,
721302 , India.
|
11:40-12:00 |
Panel Discussion |
|
|
University
at Buffalo, USA
Ludwig-Maximilians University, Germany
University
of Alberta, Canada
Indian
Institute of Chemical Technology, India
Guru
Jambheshwar University of Science and Technology, India |
March 3, 2010
(Wednesday)
13:00-18:00 |
Track
6-2: Molecular Drug Targets and Fragment based Drug Design |
Session
Chair: |
Dr. Wojciech Krzyzanski,
Department of Pharmaceutical Sciences, University at Buffalo, Buffalo,
NY 14260, USA. |
Session Co-Chair:
|
Dr.
Nazaré Soeiro |
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Title: Assessment of
Exposure to Carcinogens: Correlation of Surrogate Biomarkers with
Adducts in Target Tissues
Dr. Franky Richter, Walther Straub
Institute,
Department of Toxicology, Ludwig-Maximilians
University, Germany.
|
13:55-14:20
|
Title: Minimal
Effective Concentration and Efficacy of Epoetins
Dr. Wojciech Krzyzanski,
Department of Pharmaceutical Sciences, University at Buffalo, Buffalo,
NY 14260, USA.
|
14:20-14:45 |
Dr. Fakhreddin Jamali,
Faculty of Pharmacy & Pharmaceutical
Sciences,
University of Alberta,
Edmonton, Alberta, Canada.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Dr. Nazaré Soeiro
|
16:45-17:10 |
Title: Biophotonics:
Application towards Modern Drug Discovery
Dr. Srinivas kantevari,
Sr. Scientist,
Organic Chemistry Division-II,
Indian Institute of Chemical Technology,
Hyderabad, India.
|
17:10-17:35 |
Title: Molecular Drug
Targets for Development of Antidepressant Drugs
Dr. Dinesh Dhingra,
Assistant Professor,
Pharmacology Division,
Department of Pharmaceutical Sciences,
Guru Jambheshwar University of Science and
Technology,
Hisar-125001-Haryana, India.
|
17:35-18:00 |
Panel Discussion |
|
|
Kuwait
University, Kuwait
Panjab
University, India
Monash
Institute of Pharmaceutical Sciences, Australia
AstraZeneca R&D Mölndal, Sweden
University
of British Columbia, Canada
Rashtrasant
Tukadoji Maharaj Nagpur University, India
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track
6-3: Improving ADME/DMPK Profile |
Session
Chair: |
Dr. Aly Nada,
Assoc.Professor & Chairman,
Department of Pharmaceutics,
Faculty of Pharmacy,
Kuwait University,
POB 24923 Safat, 13110 Kuwait. |
Session Co-Chair:
|
Prof. Bhupinder
Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University,
Chandigarh, India. |
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Dr. Jian Li,
Facility for Anti-infective Drug Development and
Innovation,
Drug Delivery, Disposition and Dynamics,
Monash Institute of Pharmaceutical Sciences,
Monash University, Australia.
|
9:00-9:25 |
Dr. Hong Wan,
Lead Generation DMPK and Physical Chemistry,
AstraZeneca R&D Mölndal, Sweden.
|
9:25-9:50 |
Title: Stability and
Rat Skin Permeation of Vitamin E and Vitamin E Acetate in Cosmetic
Preparations
Dr. Aly Nada,
Assoc.Professor & Chairman,
Department of Pharmaceutics,
Faculty of Pharmacy,
Kuwait University,
POB 24923 Safat, 13110 Kuwait.
|
9:50-10:15 |
Dr. William Jia,
Department of Surgery,
Faculty of Medicine,
University of British Columbia,
Brain Research Centre, Canada.
|
10:15-10:25 |
Coffee Break |
10:25-10:50
|
Title:
Enhancing Oral Bioavailability of Drugs using Self-Emulsifying
Drug Delivery Systems
Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University,
Chandigarh, India.
|
10:50-11:15 |
Title: Pharmacokinetic
Significance of Diabetes-induced Changes in CYP3A Activity
Prof. S. N. Umathe,
Head of Pharmacology Division,
Department of Pharmaceutical Sciences,
Rashtrasant Tukadoji Maharaj Nagpur University,
Mahatma Jyotiba Fuley Shaikshanik Parisar,
Amravati Road , Nagpur,
India.
|
11:40-12:00 |
Panel Discussion |
|
|
Mayo
Clinic School of Medicine, USA
Institut
Supérieur de Biotechnologies de Sfax, Tunisie
Vaagdevi
college of Pharmacy, India
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track
6-4: PK/PD and Bioanalysis Outsourcing Alliance |
Session
Chair:
|
Prof. Debabrata Mukhopadhyay,
Department of Biochemistry and Molecular
Biology,
Mayo Clinic School of Medicine,
Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905,
USA. |
Session
Co-Chair: |
Dr.
Anupama Ramkumar, Director,
Arkus CTSS,
Ahmedabad, India.
|
13:00-13:05 |
Session Introduction |
13:30-13:55 |
Title:
More than a Co-receptor:
New Perspectives of Neuropilin-1 Function in Endothelium and Tumor Cells
Prof. Debabrata Mukhopadhyay,
Department of Biochemistry and Molecular
Biology,
Mayo Clinic School of Medicine,
Guggenheim 1401A,
200 First Street Southwest, Rochester, MN 55905,
USA.
|
13:55-14:20 |
Dr. Sofiane Bezzine
Institut Supérieur de Biotechnologies de Sfax,
Route de Soukra km 4,
Sfax 3038, Tunisie.
|
14:20-14:45 |
Dr. S.Tamilvanan
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Bioequivalence
Studies for Generics in Patients - Trials or Tribulations?
Dr. Anupama Ramkumar,
Director,
Arkus CTSS,
Ahmedabad, India.
|
16:45-17:10 |
Title:
Local Antibiotic Delivery Systems for the Treatment of Osteomyelitis,
the Use of Fibrin Clot as a Carrier- an In Vitro and In Vivo
Pharmacokinetic Study
Dr. Stefanos Tsourvakas,
Orthopaedic Department,
General Hospital of Trikala, Greece.
|
17:10-17:35 |
Title: Pharmacokinetic
Study of Hair Dye Poisoning: A Study of 50 cases
Dr. M. Nagulu,
Department of Clinical Pharmacy Services,
M.G.M Hospital, Vaagdevi college of Pharmacy,
Warangal, India.
|
17:35-18:00 |
Panel Discussion |
|
|
Central
Drug Research Institute, India
Sun
Pharma, India
Jahaharlal
Nehru Technological University, India
Satara
College of Pharmacy, India
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track
6-5: Road Map to Drug Discovery and Develoment |
Session
Chair: |
Dr. Girish kumar jain,
Head, Division of Pharmacokinetics &
Metabolism,
Central Drug Research Institute,
Lucknow-226001, India.
|
Session
Co-Chair: |
Dr. Sanjay Mandhane,
Pharmacology Division,
Sun Pharma Advanced Research Company Limited,
Atladara, Tandalja Road, Vadodara, Gujarat 390
020, India. |
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Title:
Is Natural Product Domain a Good
Hunting Hub in the Navigation of Drug Like and Drug Molecules?
Dr. A. Jayashree,
Scientist,
Jahaharlal Nehru Technological
University, Hyderabad, India.
|
13:55-14:20 |
Title:
Materials and Methods for
Innovation-Are We Ready for Drug Discovery?
Dr. Sanjay Mandhane,
Pharmacology Division,
Sun Pharma Advanced Research Company Limited,
Atladara, Tandalja Road, Vadodara, Gujarat 390
020, India.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Therapeutic
Alternatives from Venoms and Toxins : Drug Challenges of the Future
Prof. Shivaji P.Gawade,
Professor in Pharmacology and Principal,
Satara College of Pharmacy,
Plot 1539,
New Additional MIDC,
Behind Spicer India Ltd,
Degaon, Satara, M.S., India.
|
16:45-17:10 |
Title:
Human Membrane Guanylate Cyclases: Understanding the Structural Basis
of Receptor-Ligand Interactions and Approaches to Drug Design
Prof. Paul Roesch,
Research Center for Bio-Macromolecules,
U. of Bayreuth 95440 Bayreuth, Germany.
|
17:35-18:00 |
Panel Discussion |
|
|
|
|
All
India Institute of Medical Sciences, India
Govt.
College of Pharmacy, India
|
Time |
Track |
March 3, 2010
(Wednesday)
8:30-12:00 |
Track
7-1: Influence of Disease on Bioavailability |
Session
Chair: |
Call for Host |
Session Co-Chair:
|
Dr. Thirumurthy
velpandian,
Associate Professor & In-Charge,
Department of Ocular Pharmacology &
Pharmacy,
Dr.Rajendra Prasad Centre for Ophthalmic
Sciences,
All India Institute of Medical Sciences,
New Delhi, India.
|
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Title:
Liver Diseses Affecting
Bioavailability
Dr. Dibya Sundar Panda,
Institute of Pharmacy and Technology, Salipur-754202, Cuttack, India.
|
9:25-9:50 |
Title:
Pros and Cons of Ocular
bio-availability of Drugs
Dr. Thirumurthy velpandian,
Associate Professor & In-Charge,
Department of Ocular Pharmacology &
Pharmacy,
Dr.Rajendra Prasad Centre for Ophthalmic
Sciences,
All India Institute of Medical Sciences,
New Delhi, India.
|
10:15-10:25 |
Coffee Break |
10:25-10:50 |
Dr. Motte Laurence,
Université Paris,
Nanomaterials group,
CSPBAT Laboratory, France.
|
10:50-11:15 |
Title: Are
Bioavailability Studies Warranted in Specific Disease States?
Dr. S.B. Bhise, Principal,
Govt. College of Pharmacy,
Karad, India.
|
11:40-12:00 |
Panel Discussion |
|
|
Andhra University, India
Novartis,
USA
University
Children's Hospital Basel, Switzerland
University
of Kentucky School of Medicine, USA
Huashan hospital of Fudan University, China
Jagiellonian
University
Royal College of Surgeons in Ireland, Ireland
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track
7-2: Factors Influencing Bioavailability and Bioequivalence |
Session
Chair: |
Prof. T. Satyanarayana,
Principal,
College of Pharmaceutical Sciences,
Andhra University,
Visakhapatnam, India. |
Session
Co-Chair:
|
Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS),
USEH, 436/3253,
One Health Plaza,
East Hanover, NJ 07936-1080, USA.
|
13:00-13:05 |
Session Introduction |
13:05-13:30 |
Title:
Immunomodulation
by Biologic Intravenous Immunoglobulins IVIG: Immune Thrombocytopenia
ITP as a Model for the last 30 Years
Dr. Paul Imbach,
University Children's Hospital Basel UKBB, Basel, Switzerland
|
13:30-13:55
|
Title: The
Bioavailability of Heparin-binding Molecules on Vascular Walls is
Regulated by Heparan Sulfate and Flow Rate
Dr. Michael Fannon,
University of Kentucky School of Medicine,
Lexingto
|
13:55-14:20 |
Dr. Peinan Sun,
The Department of Clinical Pharmacology,
Huashan hospital of Fudan University,
Shanghai, China.
|
14:20-14:45
|
Title: Factors
Influencing Bioavailability and Bioequivalence
Prof. Vijaya Ratna,
AU College of Pharmaceutical Sciences,
Andhra University, Visakhapatnam, India.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45
|
Title: Roles of Oral
Drug Absorption, Bioavailability and Exposure Prediction in Drug
Development
Dr. Tycho Heimbach,
Novartis Institutes for BioMedical Research,
DMPK - Translational Sciences (TS),
USEH, 436/3253,
One Health Plaza,
East Hanover, NJ 07936-1080,
USA.
|
16:45-17:10 |
Title:
Combining Population-based Mechanistic Modeling of Oral Absorption and
Parameter Estimation Algorithms to Obtain Reliable Predictions of
Bioavailability
Prof. Sebastian Polak,
Jagiellonian Univ,
Krakow,
Poland and Simcyp, Poland.
|
17:10-17:35
|
Title: Aspirin
Resistance: The Role of Poor Bioavailability of Enteric Coated Aspirin
Dr. Dermot Cox,
Molecular and Cellular Therapeutics,
Royal College of Surgeons in Ireland,
123 St. Stephens Green,
Dublin 2,
Ireland.
|
17:35-18:00 |
Panel Discussion |
|
|
KLE University, India
University
of Texas at Austin, USA
Saudi Food and Drug Authority, Saudi Arabia
University of Ljubljana, Slovenia
|
March 3, 2010
(Wednesday)
8:30-12:00 |
Track
7-3: The Role of Intestinal Metabolism on Bioavailability |
Session
Chair:
|
Prof. Basavaraj K. Nanjwade,
Department of Pharmaceutics,
JN Medical college,
KLE University,
Belgaum- 590010,
Karnataka, India.
|
Session
Co-Chair: |
Call for Co-Host |
8:30-8:35 |
Session Introduction |
8:35-9:00 |
Title: Challenges in
Establishing Bioequivalence of Complex Modified Release Dosage Forms
Dr. Salomon Stavchansky, Division
of Pharmaceutics,
College of Pharmacy,
University of Texas at Austin, Austin, Texas, USA.
|
9:25-9:50 |
Dr. Abdullah Al-Mohizea,
Director of Product Evaluation and Standard
Setting Department,
Drug Sector,
Saudi Food and Drug Authority,
Riyadh, Saudi Arabia.
|
9:50-10:15 |
Title: The Importance
of Intestinal Wall Metabolism – the Case of Raloxifene
Dr. Trontelj Jurij, Dept.
Biopharmacy and Pharmacokinetics,
Faculty of Pharmacy,
University of Ljubljana Askerceva 7, Ljubljana,
Slovenia.
|
10:15-10:25 |
Coffee Break |
10:25-10:50
|
Title: Enhancing Drug
Bioavailability by Overcoming Intestinal Metabolism
Prof. Basavaraj K. Nanjwade,
Department of Pharmaceutics,
JN Medical college,
KLE University,
Belgaum- 590010,
Karnataka, India.
|
10:50-11:15 |
Title: Enhancement of
Bioavailability of Aceclofenac Using Solid Dispersion Technique
Dr. Sharma V. K,
D.J. College of Pharmacy, Modinagar, 201204, UP, India.
|
11:40-12:00 |
Panel Discussion |
|
|
Cetero Research, USA
Panacea
Biotec Ltd., India
Y.B.
Chavan College of Pharmacy, India
Panjab
University, India
Dibrugarh University, India
M. L.
Sukhadia University, India
Dr H S Gour University,
India
|
March 3, 2010
(Wednesday)
13:00-18:00 |
Track
7-4: In Vitro Methods to Determine Bioavailability & In
Vitro-In Vivo Correlations |
Session
Chair: |
Dr. Sam Raney,
Associate Director, Pre-Clinical Dermatology,
Cetero Research, Adjunct Professor of
Pharmaceutical Sciences at North Dakota State University, USA.
|
Session
Co-Chair:
|
Dr. Shivanand
Puthli, Drug Delivery Division,
Panacea Biotec Ltd., Navi-Mumbai, Maharashtra, India. |
13:00-13:05 |
Session Introduction |
13:05-13:30
|
Title:
Assessing BA/BE of
Topical Formulations In Vitro:
In Vitro – In Vivo Correlation Provides a
Practical Surrogate to Clinical BE Studies
Dr. Sam Raney,
Associate Director, Pre-Clinical Dermatology,
Cetero Research, Adjunct Professor of
Pharmaceutical Sciences at North Dakota State University, USA.
|
13:30-13:55
|
Title:
Understanding the
Significance of In-vitro/ In-vivo Correlation in Pharmacokinetic
Predictions
Dr. Shivanand Puthli,
Drug Delivery Division,
Panacea Biotec Ltd., Navi-Mumbai, Maharashtra, India.
|
13:55-14:20
|
Title: In Vitro
Methods to Determine Bioavailability & IVIVC of Oral Dosage Forms
and Drug Delivery Systems
Dr. Vijay D. Wagh,
Associate Professor In Pharmaceutics,
Y.B. Chavan College of Pharmacy, Aurangabad.
and
Editor In Chief,
Indian Journal of Pharmaceutics,
Serial Publications, Daria Ganj,
New Delhi, India.
|
14:20-14:45
|
Title: Endeavoring
Biowaivers Using IVIVC: Shifting Paradigms
Prof. Bhupinder Singh Bhoop,
Pharmaceutics & Pharmacokinetics,
Univ Inst Pharm Sci (UGC Center of Adv Studies),
Dean (Alumni Relations), Panjab University,
Chandigarh, India.
|
14:45-16:20 |
Coffee Break & Poster Session |
16:20-16:45 |
Title: Transdermal
Bioavailability of Trazodone Hydrochloride: Invitro-Invivo Correlation
Dr. Malay K. Das,
Division of Pharmaceutics,
Department of Pharmaceutical Sciences,
Dibrugarh University,
Dibrugarh 786004, India.
|
16:45-17:10 |
Title: Effect of Test
Parameters on In-vitro Method to Determine Bioavailability of Dosage
Forms
Dr. Abhishek kumar Jain,
Research Scholar and Lecturer,
Department of Pharmaceutical Science,
M. L. Sukhadia University,
Udaipur, Rajasthan, India.
|
17:10-17:35 |
Dr. Avijeet Jain,
Research Scholar,
Natural Product Research Laboratory,
Dept of Pharmaceutical Sciences,
Dr H S Gour University,
Sagar, MP, India.
|
17:35-18:00 |
Panel Discussion |
|
|
|
|
|
University of Notre Dame, USA
Faculty of Medicine Siriraj Mahidol University, Thailand
Nova Southeastern University, USA
The Australian National University Medical School, University of
Canberra, Australia
University of Hyderabad, India
Panjab University, Chandigarh, India
Institute of Biotechnology and Antibiotics, Warsaw, Poland
Texas Tech School of Pharmacy, USA
University of Petra, Jordan
Jadavpur University, India
University of British Columbia, Canada
Canadian Society for Pharmaceutical Sciences, Canada
National University of Singapore, Singapore
King Saud University, Saudi Arabia
Widener University, USA
Stanford University School of Medicine, USA
University at Buffalo, State University of New York, USA
School of Biological Sciences, University of Edinburgh, UK
Chungnam National University, Korea
Harvard Medical School, USA
Polish Academy of Sciences, Poland
University of Trieste, Italy
College of Pharmaceutical Sciences, MAHE, India
Medical School, University of Athens, Greece
Universiade Federal da Bahia, Instituto de Ciências da Saude, Brazil
University of Region of Cariri - URCA, Brazil
Tabriz University of Medical Sciences, Iran
Johns Hopkins University, USA
Creighton University Medical Center and University of Nebraska Medical
Center, USA
University of Pisa, Italy
University of Notre Dame, USA
Faculty of Medicine Siriraj Mahidol University, Thailand
Nova Southeastern University, USA
The Australian National University Medical School, University of
Canberra, Australia
University of Hyderabad, India
Panjab University, Chandigarh, India
Institute of Biotechnology and Antibiotics, Warsaw, Poland
Texas Tech School of Pharmacy, USA
University of Petra, Jordan
Jadavpur University, India
University of British Columbia, Canada
Canadian Society for Pharmaceutical Sciences, Canada
National University of Singapore, Singapore
King Saud University, Saudi Arabia
Widener University, USA
Stanford University School of Medicine, USA
University at Buffalo, State University of New York, USA
School of Biological Sciences, University of Edinburgh, UK
Chungnam National University, Korea
Harvard Medical School, USA
Polish Academy of Sciences, Poland
University of Trieste, Italy
College of Pharmaceutical Sciences, MAHE, India
Medical School, University of Athens, Greece
Universiade Federal da Bahia, Instituto de Ciências da Saude, Brazil
University of Region of Cariri - URCA, Brazil
Tabriz University of Medical Sciences, Iran
Johns Hopkins University, USA
Creighton University Medical Center and University of Nebraska Medical
Center, USA
University of Pisa, Italy
|
|
US Pharmacopeia, USA
Food and Drug Administration, USA
University Hospital Zurich, Switzerland
B. V. Patel Perd Centre, India
Guy's Hospital, UK
Hôpital Saint-Antoine, Paris
A. Manzoni Hospital, Italy
Kazusa DNA Research Institute, Japan
Pharmaceutics Int., Inc., USA
Agilent Technologies, USA
Central Drug Research Institute, India
EMF Consulting, France
Hopital Cochin, Paris
Boys Town National Research Hospital, Omaha, USA
Aurobindo Pharma Ltd., India
US Pharmacopeia, USA
Food and Drug Administration, USA
University Hospital Zurich, Switzerland
B. V. Patel Perd Centre, India
Guy's Hospital, UK
Hôpital Saint-Antoine, Paris
A. Manzoni Hospital, Italy
Kazusa DNA Research Institute, Japan
Pharmaceutics Int., Inc., USA
Agilent Technologies, USA
Central Drug Research Institute, India
EMF Consulting, France
Hopital Cochin, Paris
Boys Town National Research Hospital, Omaha, USA
Aurobindo Pharma Ltd., India
|
|
|